# Adversarial Review Changelog
# Paper: SparsityLoRA
# Phase 6.5 — Adversarial Review v2.0

---

## Round 1 Revisions (R1 → 06_paper_r1.md)

**Date**: 2026-05-10
**Revision Agent**: R1
**Input**: 06_paper.md + 065_review_r1.md

### Issues Addressed

#### MAJOR-001: Cross-epsilon tau claim corrected (ACCEPTED)

- **Issue**: Abstract, Introduction, Discussion, and Conclusion claimed cross-ε τ > 0.96 but actual minimum is 0.9597
- **Fix**: Changed all instances of ">0.96" to ">0.95" with precise minimum noted where appropriate
- **Locations changed**:
  1. Abstract para 2: "exceed $0.96$" → "exceed $0.95$"
  2. Introduction §1 (inline text, line 75): "exceed $0.96$" → "exceed $0.95$ (minimum: $\tau=0.9597$)"
  3. Introduction §1 contribution #3: "> 0.96" → "> 0.95" with minimum value added
  4. Discussion §6.1: "τ > 0.96" → "τ > 0.95"
  5. Conclusion §7: "τ > 0.96" → "τ > 0.95, minimum 0.9597"
- **Evidence**: Ground truth minimum = 0.9597 (h-m2/04_validation.md); sections/05_results.md correctly stated ">0.95"

#### MAJOR-002: Act-LoRA citation resolved (PARTIAL — requires human follow-up)

- **Issue**: "Act-LoRA [UNVERIFIED]" placeholder cannot appear in submitted manuscript
- **Fix**: 
  1. Changed text from "Act-LoRA [UNVERIFIED]" to "Act-LoRA \citep{actlora2025mdpi}" with softer framing ("A contemporaneous approach, Act-LoRA, ...")
  2. Added placeholder BibTeX entry `actlora2025mdpi` to 06_references.bib with verification note
- **Status**: PARTIAL — BibTeX placeholder added; human reviewer must verify author names, title, volume, pages, DOI
- **Alternative if unverifiable**: Remove citation and keep text as "A contemporaneous approach (Act-LoRA, MDPI 2025)..."

### Sections Modified

| Section | Change |
|---------|--------|
| Abstract | τ threshold: ">0.96" → ">0.95" |
| Introduction §1 inline | τ threshold corrected + minimum added |
| Introduction §1 contribution #3 | τ threshold corrected + minimum added |
| Discussion §6.1 | τ reference corrected |
| Conclusion §7 | τ reference corrected + minimum added |
| Related Work §2.1 | Act-LoRA citation changed from [UNVERIFIED] to \citep{actlora2025mdpi} |

### Word Count Delta
- Approximate: +12 words (minimum values added to three locations)

### Issues NOT Fixed (MINOR — Deferred to Human Review)
- MINOR-001: "first systematic characterization" contribution bullet precision
- MINOR-002: Figure 1 caption expansion
- MINOR-003: SiLU soft-sparsity limitation elaboration
- MINOR-004: ARD-LoRA/La-LoRA/Sensitivity-LoRA citation placeholders in §2.1

---

## Round 2 Revisions (R2 → 06_paper_r2.md)

**Date**: 2026-05-10
**Revision Agent**: R2
**Input**: 06_paper_r1.md + 065_review_r2.md

### Issues Addressed

**R2 found ZERO FATAL or MAJOR issues.** All R1 corrections verified accurate via Serena MCP searches against actual Phase 4 validation files (h-e1, h-m1, h-m2).

**Verification results:**
- CV=0.544: VERIFIED ✅
- ICC(3,k)=0.9846 [CI: 0.97, 0.99]: VERIFIED ✅
- τ_min=0.7339: VERIFIED ✅
- Cross-ε τ min=0.9597: VERIFIED ✅ (R1 fix ">0.95" is correct)
- All p-values: VERIFIED ✅
- Model (LLaMA-3.1-8B): VERIFIED ✅
- Duration (~5 minutes): VERIFIED ✅

### Sections Modified

None — R2 produced no changes to paper content.

### Word Count Delta
- 0 (no changes)

### 06_paper_r2.md
Identical to 06_paper_r1.md — R2 verification passed with no corrections needed.

### Convergence Decision
After R2: FATAL=0, MAJOR=0, Persuasiveness=PASSED, Rounds=2 → **CONVERGED**
Proceeding to Step 7: Finalize.

---

## Final Summary

**Total Revisions Made**: 6 text changes (all in R1)
**Sections Modified**: Abstract, Introduction §1, Discussion §6.1, Conclusion §7, Related Work §2.1
**Word Count Change**: ~4550 → ~4562 (+12 words, precision additions)

**Review Process**:
- Started: 2026-05-10T00:00:00Z
- Completed: 2026-05-10T02:00:00Z
- Rounds: 2 (R1 + R2)
- Personas Used: accuracy_checker, bored_reviewer, skeptical_expert

**Files Generated**:
- 06_paper_r1.md (R1 revised paper)
- 06_paper_r2.md (R2 verified, identical to R1)
- 06_paper_final.md (final paper)
- 065_review_r1.md (R1 adversarial review)
- 065_review_r2.md (R2 verification review)
- 065_review_summary.md (consolidated summary)
- 065_human_review_notes.md (MINOR issues for human review)
- 065_changelog.md (this file)

**Next Phase**: Phase 6.5.1 (Overleaf LaTeX/PDF generation)

---
